Literature DB >> 17229977

Estrogens and epilepsy: why are we so excited?

Jana Velísková1.   

Abstract

Estrogens are essential for normal brain function throughout life. The source of estrogens is not only from the periphery, but local production has also been demonstrated in the CNS. Actions of estrogens involve a variety of effects, which include modulation of gene expression, regulation of neurotransmitter release, or direct inter-actions with neurotransmitter receptors. By these effects, estrogens affect neuronal excitability and thus may play an important role in seizure disorders. Although the original clinical as well as animal studies suggest that estrogens have exclusively proconvulsant properties, it has now become clear that estrogens also produce anticonvulsant effects. These opposite effects of estrogens on seizures may depend on treatment duration, latency prior to seizure testing, mode of administration, estrogen dose and hormonal status, estrogenic species, the region/neurotransmitter system involved, seizure type/model used, and sex. Animal data also suggest that estrogens, specifically beta-estradiol, have neuroprotective effects on seizure-induced hippocampal damage. Further studies are necessary to understand the role of estrogens in seizure disorders. Such under-standing is important, especially for women with epilepsy, to make qualified decisions regarding administration of contraceptives and hormonal replacement therapy as well as for the design of new therapeutic strategies for better seizure control and prevention of seizure-induced neuronal damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229977     DOI: 10.1177/1073858406295827

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.519


  30 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Males still dominate animal studies.

Authors:  Irving Zucker; Annaliese K Beery
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

3.  Females, their estrogens, and seizures.

Authors:  Jana Velísková; Glendis De Jesus; Ramanjot Kaur; Libor Velísek
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

4.  Genistein modulation of seizure: involvement of estrogen and serotonin receptors.

Authors:  Saeed Amiri Gheshlaghi; Razieh Mohammad Jafari; Mohammad Algazo; Nastaran Rahimi; Hussein Alshaib; Ahmad Reza Dehpour
Journal:  J Nat Med       Date:  2017-04-24       Impact factor: 2.343

Review 5.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

Review 6.  The role of sex steroids in catamenial epilepsy and premenstrual dysphoric disorder: implications for diagnosis and treatment.

Authors:  Constance Guille; Susan Spencer; Idil Cavus; C Neill Epperson
Journal:  Epilepsy Behav       Date:  2008-03-17       Impact factor: 2.937

7.  Estrogen increases latencies to seizures and levels of 5alpha-pregnan-3alpha-ol-20-one in hippocampus of wild-type, but not 5alpha-reductase knockout, mice.

Authors:  Danielle M Osborne; Cheryl A Frye
Journal:  Epilepsy Behav       Date:  2009-09-25       Impact factor: 2.937

Review 8.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

9.  Proconvulsant effects of estriol, the third estrogen, in the mouse PTZ-kindling model.

Authors:  Aakifa Ahmad; Divya Vohora
Journal:  Neurol Sci       Date:  2014-04-19       Impact factor: 3.307

10.  The impact of gonadectomy and adrenalectomy on acute withdrawal severity in male and female C57BL/6J and DBA/2J mice following a single high dose of ethanol.

Authors:  Katherine R Gililland; Deborah A Finn
Journal:  Alcohol Clin Exp Res       Date:  2007-09-11       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.